Neoplasms

Digestive System Diseases

All Conditions

Rare Diseases

Stomach Neoplasms

Carcinoma

Carcinoma, Hepatocellular

Esophageal Neoplasms

Adenocarcinoma

Cholangiocarcinoma

Neuroendocrine Tumors

Gastrointestinal Neoplasms

Digestive System Neoplasms

Intestinal Neoplasms

Gastrointestinal Diseases

Intestinal Diseases

Neoplasms, Glandular and Epithelial

Neoplasms by Histologic Type

Neuroectodermal Tumors

Neuroectodermal Tumors, Primitive

Neoplasms, Germ Cell and Embryonal

Neoplasms, Nerve Tissue

Stomach Cancer

Esophageal Cancer

Bile Duct Cancer

Neuroendocrine Tumor

Neuroepithelioma

Patients have "serious illness conversation" within 3 wks of randomization and every 3 months thereafter.

Patients have conversations as determined by treating team (but not using SICG tool).

The Serious Illness Conversation Guide (SICG) is a structured communication template designed to provide effective tool in initiating advanced care planning discussion with patients.

Serious Illness Conversation Guide (SICG)

Quality of life survey by questionnaire (FACT-G) given every three months

Quality of Life (QOL) survey

Tyler P Johnson, MD

The purpose of the study is to determine whether standardized implementation of a scripted template for discussing important issues that arise near the end of life improves the care of those who have advanced cancer.

Primary Objective: To determine whether the Serious Illness Conversation Guide will improve the consistency with which providers have and document conversations regarding patients' goals and priorities as they near the end of life.

Secondary Objectives: 1. To assess whether having conversations as per this model will improve the quality of care near the end of life as determined by appropriate care in concordance with their goals of care.

2. To assess whether having conversations as per this model will improve patient Quality of Life (QOL) as per a validated scale.

3. To assess in patients with concordant care whether this model will improve patient QOL as per a validated scale 4. To assess provider opinions about end-of-life conversations.

Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers

A Randomized, Controlled Trial Examining the Use of The "Serious Illness Conversation Guide" (SICG) in Patients With Advanced Gastro-Intestinal Cancers

Difference in proportions of patients who have documented goals of care in medical records, assessed after death, for both arms

Proportion of patients receiving appropriate care in line with their goals of care toward the end of life, by arm will be assessed.

Comparison of survey QOL measures by section for control and intervention arms will be done by Functional Assessment of Cancer Therapy (FACT-G) , version 4 scale. It is a 28-item validated QoL questionnaire in patients receiving cancer treatment. All subscales are summed together to arrive at a total score. A higher point value is considered a better quality of life score

Comparison of survey QOL measures overall for control and intervention arms will be done by Functional Assessment of Cancer Therapy (FACT-G) , version 4 scale. It is a 28-item validated QoL questionnaire in patients receiving cancer treatment. All subscales are summed together to arrive at a total score. A higher point value is considered a better quality of life score

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers	NCT04077372	Gastrointestina... Colorectal Canc... Pancreatic Aden... Gastric Cancer Esophageal Canc... Cholangiocarcin... Hepatocellular ... Neuroendocrine ... GIST, Malignant	Serious Illness... Quality of Life...	-	Stanford University
Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers	NCT04077372	Gastrointestina... Colorectal Canc... Pancreatic Aden... Gastric Cancer Esophageal Canc... Cholangiocarcin... Hepatocellular ... Neuroendocrine ... GIST, Malignant	Serious Illness... Quality of Life...	-	Stanford University

Spots Global Cancer Trial Database for quality of life (qol) survey